Cargando…

Proteomic profiling reveals mitochondrial dysfunction in the cerebellum of transgenic mice overexpressing DYRK1A, a Down syndrome candidate gene

INTRODUCTION: DYRK1A is a dual-specificity kinase that is overexpressed in Down syndrome (DS) and plays a key role in neurogenesis, neuronal differentiation and function, cognitive phenotypes, and aging. Dyrk1A has also been implicated in cerebellar abnormalities observed in association with DS, and...

Descripción completa

Detalles Bibliográficos
Autores principales:	Ortega, Mireia, De Toma, Ilario, Fernández-Blanco, Álvaro, Calderón, Anna, Barahona, Lucía, Trullàs, Ramón, Sabidó, Eduard, Dierssen, Mara
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2022
Materias:	Molecular Neuroscience
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9800213/ https://www.ncbi.nlm.nih.gov/pubmed/36590914 http://dx.doi.org/10.3389/fnmol.2022.1015220

Ejemplares similares

DYRK1A Overexpression Alters Cognition and Neural-Related Proteomic Pathways in the Hippocampus That Are Rescued by Green Tea Extract and/or Environmental Enrichment
por: De Toma, Ilario, et al.
Publicado: (2019)

Network analysis of Down syndrome and SARS-CoV-2 identifies risk and protective factors for COVID-19
por: De Toma, Ilario, et al.
Publicado: (2021)

Meta-analysis of transcriptomic data reveals clusters of consistently deregulated gene and disease ontologies in Down syndrome
por: De Toma, Ilario, et al.
Publicado: (2021)

Dyrk1A Is Dynamically Expressed on Subsets of Motor Neurons and in the Neuromuscular Junction: Possible Role in Down Syndrome
por: Arque, Gloria, et al.
Publicado: (2013)

Social Factors Influence Behavior in the Novel Object Recognition Task in a Mouse Model of Down Syndrome
por: Sierra, Cesar, et al.
Publicado: (2021)

Overexpression of DYRK1A, a Down Syndrome Candidate gene, Impairs Primordial Germ Cells Maintenance and Migration in zebrafish
por: Liu, Yanyan, et al.
Publicado: (2017)

NGF Upregulates the Plasminogen Activation Inhibitor-1 in Neurons via the Calcineurin/NFAT Pathway and the Down Syndrome-Related Proteins DYRK1A and RCAN1 Attenuate This Effect
por: Stefos, Georgios C., et al.
Publicado: (2013)

Molecular Rescue of Dyrk1A Overexpression Alterations in Mice with Fontup(®) Dietary Supplement: Role of Green Tea Catechins
por: Gu, Yuchen, et al.
Publicado: (2020)

Deficits in neuronal architecture but not over-inhibition are main determinants of reduced neuronal network activity in a mouse model of overexpression of Dyrk1A
por: Manubens-Gil, Linus, et al.
Publicado: (2023)

The lncRNA Snhg11, a new candidate contributing to neurogenesis, plasticity and memory deficits in Down syndrome
por: Sierra, Cesar, et al.
Publicado: (2023)

Overexpression of Dyrk1A Is Implicated in Several Cognitive, Electrophysiological and Neuromorphological Alterations Found in a Mouse Model of Down Syndrome
por: García-Cerro, Susana, et al.
Publicado: (2014)

Re-establishment of the epigenetic state and rescue of kinome deregulation in Ts65Dn mice upon treatment with green tea extract and environmental enrichment
por: De Toma, I., et al.
Publicado: (2020)

DYRK1A, a Novel Determinant of the Methionine-Homocysteine Cycle in Different Mouse Models Overexpressing this Down-Syndrome-Associated Kinase
por: Noll, Christophe, et al.
Publicado: (2009)

A novel inhibitor rescues cerebellar defects in a zebrafish model of Down syndrome–associated kinase Dyrk1A overexpression
por: Buchberger, Astrid, et al.
Publicado: (2021)

Dyrk1A overexpression leads to increase of 3R-tau expression and cognitive deficits in Ts65Dn Down syndrome mice
por: Yin, Xiaomin, et al.
Publicado: (2017)

Impaired Spatial Learning Strategies and Novel Object Recognition in Mice Haploinsufficient for the Dual Specificity Tyrosine-Regulated Kinase-1A (Dyrk1A)
por: Arqué, Glòria, et al.
Publicado: (2008)

Rethinking Intellectual Disability from Neuro- to Astro-Pathology
por: Fernández-Blanco, Álvaro, et al.
Publicado: (2020)

A comprehensive proteomics-based interaction screen that links DYRK1A to RNF169 and to the DNA damage response
por: Roewenstrunk, Julia, et al.
Publicado: (2019)

DYRK1A (Dual-Specificity Tyrosine-Phosphorylated and -Regulated Kinase 1A): A Gene with Dosage Effect During Development and Neurogenesis
por: Dierssen, M., et al.
Publicado: (2006)

Neuronal overexpression of Alzheimer's disease and Down's syndrome associated DYRK1A/minibrain gene alters motor decline, neurodegeneration and synaptic plasticity in Drosophila
por: Lowe, Simon A., et al.
Publicado: (2019)

New Perspectives of Dyrk1A Role in Neurogenesis and Neuropathologic Features of Down Syndrome
por: Park, Joongkyu, et al.
Publicado: (2013)

Structures of Down Syndrome Kinases, DYRKs, Reveal Mechanisms of Kinase Activation and Substrate Recognition
por: Soundararajan, Meera, et al.
Publicado: (2013)

Green Tea Polyphenols Rescue of Brain Defects Induced by Overexpression of DYRK1A
por: Guedj, Fayçal, et al.
Publicado: (2009)

Fluorescent transgenic mouse models for whole-brain imaging in health and disease
por: Arias, Adrian, et al.
Publicado: (2022)

Targeting trisomic treatments: optimizing Dyrk1a inhibition to improve Down syndrome deficits
por: Stringer, Megan, et al.
Publicado: (2017)

DYRK1A Overexpression in Mice Downregulates the Gonadotropic Axis and Disturbs Early Stages of Spermatogenesis
por: Dard, Rodolphe, et al.
Publicado: (2021)

Immune Dysregulation and the Increased Risk of Complications and Mortality Following Respiratory Tract Infections in Adults With Down Syndrome
por: Illouz, Tomer, et al.
Publicado: (2021)

Hippocampal changes produced by overexpression of the human CHRNA5/A3/B4 gene cluster may underlie cognitive deficits rescued by nicotine in transgenic mice
por: Molas, Susanna, et al.
Publicado: (2014)

Zebrafish knockout of Down syndrome gene, DYRK1A, shows social impairments relevant to autism
por: Kim, Oc-Hee, et al.
Publicado: (2017)

Correction of cognitive deficits in mouse models of Down syndrome by a pharmacological inhibitor of DYRK1A
por: Nguyen, Thu Lan, et al.
Publicado: (2018)

DYRK1A Protein, A Promising Therapeutic Target to Improve Cognitive Deficits in Down Syndrome
por: Feki, Anis, et al.
Publicado: (2018)

DYRK1a Inhibitor Mediated Rescue of Drosophila Models of Alzheimer’s Disease-Down Syndrome Phenotypes
por: Zhu, Bangfu, et al.
Publicado: (2022)

Mutational analysis of two residues in the DYRK homology box of the protein kinase DYRK1A
por: Widowati, Esti Wahyu, et al.
Publicado: (2018)

Selective Transgenic Expression of Mutant Ubiquitin in Purkinje Cell Stripes in the Cerebellum
por: Verheijen, Bert M., et al.
Publicado: (2016)

DCAF7/WDR68 is required for normal levels of DYRK1A and DYRK1B
por: Yousefelahiyeh, Mina, et al.
Publicado: (2018)

Differential maturation and chaperone dependence of the paralogous protein kinases DYRK1A and DYRK1B
por: Papenfuss, Marco, et al.
Publicado: (2022)

Specific Susceptibility to COVID-19 in Adults with Down Syndrome
por: Illouz, Tomer, et al.
Publicado: (2021)

Hippocampal overexpression of Down syndrome cell adhesion molecule in amyloid precursor protein transgenic mice
por: Jia, Y.L., et al.
Publicado: (2017)

Novel DYRK1A Inhibitor Rescues Learning and Memory Deficits in a Mouse Model of Down Syndrome
por: Stensen, Wenche, et al.
Publicado: (2021)

Craniofacial dysmorphology in Down syndrome is caused by increased dosage of Dyrk1a and at least three other genes
por: Redhead, Yushi, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_3693crltu63r7brt3p26ri3okj